Abstract
The most effective way of communicating new research findings is by publishing them in a peer-reviewed journal which is widely read and highly respected. To ensure that important new data are shared with the appropriate audience in a timely manner, a number of important considerations need to be taken into account when choosing a suitable journal. This article provides an analysis of journals which publish original articles describing studies of vaccines against human infectious diseases. A search of PubMed identified over 80 journals which recently published vaccine-related studies. These journals were filtered according to impact factor and number and percentage of vaccine-related studies published from 2006 to 2010, resulting in a core of 32 journals which frequently publish studies of vaccines against human infectious diseases. A survey was then undertaken to gather additional information with respect to acceptance rate, average time needed from manuscript submission to acceptance and from acceptance to publication. This dataset should provide a useful source of metrics which can help ensure that manuscripts are submitted to the most appropriate journal.
Additional information
Notes on contributors
Daniel Portsmouth
Daniel Portsmouth studied Biology at the University of Warwick, UK, and holds a PhD from the University of Vienna, Austria. Before joining the Baxter Vaccine R&D team in 2009, Daniel worked on the development of viral vectors for cancer gene therapy at the University of Veterinary Medicine in Vienna.